Literature DB >> 21543334

Beta-arrestin-1 protein represses diet-induced obesity.

Le-nan Zhuang1, Wen-xiang Hu, Ming-liang Zhang, Shun-mei Xin, Wei-ping Jia, Jian Zhao, Gang Pei.   

Abstract

Diet-related obesity is a major metabolic disorder. Excessive fat mass is associated with type 2 diabetes, hepatic steatosis, and arteriosclerosis. Dysregulation of lipid metabolism and adipose tissue function contributes to diet-induced obesity. Here, we report that β-arrestin-1 knock-out mice are susceptible to diet-induced obesity. Knock-out of the gene encoding β-arrestin-1 caused increased fat mass accumulation and decreased whole-body insulin sensitivity in mice fed a high-fat diet. In β-arrestin-1 knock-out mice, we observed disrupted food intake and energy expenditure and increased macrophage infiltration in white adipose tissue. At the molecular level, β-arrestin-1 deficiency affected the expression of many lipid metabolic genes and inflammatory genes in adipose tissue. Consistently, transgenic overexpression of β-arrestin-1 repressed diet-induced obesity and improved glucose tolerance and systemic insulin sensitivity. Thus, our findings reveal that β-arrestin-1 plays a role in metabolism regulation.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21543334      PMCID: PMC3151082          DOI: 10.1074/jbc.M111.223206

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  31 in total

Review 1.  Obesity and the regulation of energy balance.

Authors:  B M Spiegelman; J S Flier
Journal:  Cell       Date:  2001-02-23       Impact factor: 41.582

Review 2.  Obesity and insulin resistance.

Authors:  B B Kahn; J S Flier
Journal:  J Clin Invest       Date:  2000-08       Impact factor: 14.808

3.  Differential regulation of beta-arrestin 1 and beta-arrestin 2 gene expression in rat brain by morphine.

Authors:  X L Fan; J S Zhang; X Q Zhang; W Yue; L Ma
Journal:  Neuroscience       Date:  2003       Impact factor: 3.590

4.  Association of beta-arrestin and TRAF6 negatively regulates Toll-like receptor-interleukin 1 receptor signaling.

Authors:  Yaya Wang; Yawei Tang; Lin Teng; Yalan Wu; Xiaohui Zhao; Gang Pei
Journal:  Nat Immunol       Date:  2005-12-25       Impact factor: 25.606

5.  Dose-response relationship of insulin to glucose fluxes in the awake and unrestrained mouse.

Authors:  H Q Shen; J S Zhu; A D Baron
Journal:  Metabolism       Date:  1999-08       Impact factor: 8.694

Review 6.  Obesity.

Authors:  P Björntorp
Journal:  Lancet       Date:  1997-08-09       Impact factor: 79.321

7.  Activation and targeting of extracellular signal-regulated kinases by beta-arrestin scaffolds.

Authors:  L M Luttrell; F L Roudabush; E W Choy; W E Miller; M E Field; K L Pierce; R J Lefkowitz
Journal:  Proc Natl Acad Sci U S A       Date:  2001-02-20       Impact factor: 11.205

8.  Dok1 mediates high-fat diet-induced adipocyte hypertrophy and obesity through modulation of PPAR-gamma phosphorylation.

Authors:  Tetsuya Hosooka; Tetsuya Noguchi; Ko Kotani; Takehiro Nakamura; Hiroshi Sakaue; Hiroshi Inoue; Wataru Ogawa; Kazutoshi Tobimatsu; Kazuo Takazawa; Mashito Sakai; Yasushi Matsuki; Ryuji Hiramatsu; Tomoharu Yasuda; Mitchell A Lazar; Yuji Yamanashi; Masato Kasuga
Journal:  Nat Med       Date:  2008-01-20       Impact factor: 53.440

9.  Beta-Arrestin-1 mediates glucagon-like peptide-1 signaling to insulin secretion in cultured pancreatic beta cells.

Authors:  Noriyuki Sonoda; Takeshi Imamura; Takeshi Yoshizaki; Jennie L Babendure; Juu-Chin Lu; Jerrold M Olefsky
Journal:  Proc Natl Acad Sci U S A       Date:  2008-04-29       Impact factor: 11.205

10.  Critical regulation of CD4+ T cell survival and autoimmunity by beta-arrestin 1.

Authors:  Yufeng Shi; Yan Feng; Jiuhong Kang; Chang Liu; Zhenxin Li; Dangsheng Li; Wei Cao; Ju Qiu; Zhengliang Guo; Enguang Bi; Lei Zang; Chuanzhen Lu; Jingwu Z Zhang; Gang Pei
Journal:  Nat Immunol       Date:  2007-07-08       Impact factor: 25.606

View more
  16 in total

Review 1.  Scaffold Proteins: From Coordinating Signaling Pathways to Metabolic Regulation.

Authors:  Yves Mugabo; Gareth E Lim
Journal:  Endocrinology       Date:  2018-11-01       Impact factor: 4.736

2.  Beta-arrestin-1 protein represses adipogenesis and inflammatory responses through its interaction with peroxisome proliferator-activated receptor-gamma (PPARgamma).

Authors:  Le-nan Zhuang; Wen-xiang Hu; Shun-mei Xin; Jian Zhao; Gang Pei
Journal:  J Biol Chem       Date:  2011-06-23       Impact factor: 5.157

3.  Metabolic effects of carvedilol through β-arrestin proteins: investigations in a streptozotocin-induced diabetes rat model and in C2C12 myoblasts.

Authors:  Berna Güven; Zümra Kara; Arzu Onay-Beşikci
Journal:  Br J Pharmacol       Date:  2020-11-15       Impact factor: 8.739

4.  Mammalian α arrestins link activated seven transmembrane receptors to Nedd4 family e3 ubiquitin ligases and interact with β arrestins.

Authors:  Fortune F Shea; Jennie L Rowell; Yechaowei Li; Tien-Hsien Chang; Carlos E Alvarez
Journal:  PLoS One       Date:  2012-12-07       Impact factor: 3.240

5.  β-arrestin-1 contributes to brown fat function and directly interacts with PPARα and PPARγ.

Authors:  Congcong Wang; Xianglu Zeng; Zhaocai Zhou; Jian Zhao; Gang Pei
Journal:  Sci Rep       Date:  2016-06-15       Impact factor: 4.379

6.  β-arrestin-2 is an essential regulator of pancreatic β-cell function under physiological and pathophysiological conditions.

Authors:  Lu Zhu; Joana Almaça; Prasanna K Dadi; Hao Hong; Wataru Sakamoto; Mario Rossi; Regina J Lee; Nicholas C Vierra; Huiyan Lu; Yinghong Cui; Sara M McMillin; Nicole A Perry; Vsevolod V Gurevich; Amy Lee; Bryan Kuo; Richard D Leapman; Franz M Matschinsky; Nicolai M Doliba; Nikhil M Urs; Marc G Caron; David A Jacobson; Alejandro Caicedo; Jürgen Wess
Journal:  Nat Commun       Date:  2017-02-01       Impact factor: 14.919

7.  ARRB1 ameliorates liver ischaemia/reperfusion injury via antagonizing TRAF6-mediated Lysine 6-linked polyubiquitination of ASK1 in hepatocytes.

Authors:  Xiaoliang Xu; Zechuan Zhang; Yijun Lu; Qikai Sun; Yang Liu; Qiaoyu Liu; Wenfang Tian; Yin Yin; Hailong Yu; Beicheng Sun
Journal:  J Cell Mol Med       Date:  2020-05-23       Impact factor: 5.310

8.  An ACACB variant implicated in diabetic nephropathy associates with body mass index and gene expression in obese subjects.

Authors:  Lijun Ma; Mariana Murea; James A Snipes; Alejandra Marinelarena; Jacqueline Krüger; Pamela J Hicks; Kurt A Langberg; Meredith A Bostrom; Jessica N Cooke; Daisuke Suzuki; Tetsuya Babazono; Takashi Uzu; Sydney C W Tang; Ashis K Mondal; Neeraj K Sharma; Sayuko Kobes; Peter A Antinozzi; Matthew Davis; Swapan K Das; Neda Rasouli; Philip A Kern; Nathan J Shores; Lawrence L Rudel; Matthias Blüher; Michael Stumvoll; Donald W Bowden; Shiro Maeda; John S Parks; Peter Kovacs; Robert L Hanson; Leslie J Baier; Steven C Elbein; Barry I Freedman
Journal:  PLoS One       Date:  2013-02-27       Impact factor: 3.240

9.  Fibroblast growth factor 21 increases insulin sensitivity through specific expansion of subcutaneous fat.

Authors:  Huating Li; Guangyu Wu; Qichen Fang; Mingliang Zhang; Xiaoyan Hui; Bin Sheng; Liang Wu; Yuqian Bao; Peng Li; Aimin Xu; Weiping Jia
Journal:  Nat Commun       Date:  2018-01-18       Impact factor: 14.919

10.  Beneficial metabolic role of β-arrestin-1 expressed by AgRP neurons.

Authors:  Sai P Pydi; Zhenzhong Cui; Zhenyan He; Luiz F Barella; Jonathan Pham; Yinghong Cui; Douglas J Oberlin; Hale Ergin Egritag; Nikhil Urs; Oksana Gavrilova; Gary J Schwartz; Christoph Buettner; Kevin W Williams; Jürgen Wess
Journal:  Sci Adv       Date:  2020-06-03       Impact factor: 14.136

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.